Name: Oncological Therapeutics
Brand: Rafael Holdings, Inc.

Health and Medical

Rafael Holdings’ investment in Cyclo Therapeutics provides access to a pipeline of novel cancer therapies, specifically focused on Niemann Pick Type C1. This represents a significant opportunity to deliver a breakthrough treatment option for patients with this challenging disease.

Cyclo Therapeutics Pipeline

Science and Engineering

Biotechnology

Rafael Holdings, Inc.

New Jersey

Biopharma

Life Science

Rafael Holdings is dedicated to the discovery and development of novel oncological therapeutics to improve and extend the lives of patients.

Oncological Therapeutics

Other products/services from Rafael Holdings, Inc.

Cyclo Therapeutics Pipeline

N/A